US Senate: insulin makers raised list prices in lockstep; PBMs rewarded hikes
Dated 14 January 2021: US Senate: insulin makers raised list prices in lockstep; PBMs rewarded hikes. In the causal graph this event weakens Access to Essential Medicines, a driver that weakens Proportion of the population with positive out-of-pocket household expenditure on health exceeding 40% of household discretionary budget, by location, quintile, type of household and characteristics of the head of household (%) — a worsening welfare path.
Who was responsible
Contribution type and responsibility level for each recorded actor — not sole-author shorthand.
No public contributors are listed for this fact.
What changed
Fact → Driver → Indicator. Relationship strength orders the paths; it is not the observed indicator movement.
- FactUS Senate: insulin makers raised list prices in lockstep; PBMs rewarded hikes
- weakensDriverAccess to Essential Medicines
- weakensIndicators (2)Proportion of the population with positive out-of-pocket household expenditure on health exceeding 40% of household discretionary budget, by location, quintile, type of household and characteristics of the head of household (%)
provisional weight · verified
Weakens · 78% impact strength (driver → indicator)
Observed
26% · 0.23 below the normal line (2022)
Better than normal5 readings, 2018–2022: fell from 26.9% to 26%.
Above normal = worse
Weakens · 71% impact strength (driver → indicator)
Observed
4.07% of people reporting a medical need · 2.57 above the normal line (2025)
Worse than normal5 readings, 2021–2025: rose from 3.8% of people reporting a medical need to 4.07% of people reporting a medical need.
Above normal = worse
Causal path
How this event connects to drivers and indicators in the graph.
- FactUS Senate: insulin makers raised list prices in lockstep; PBMs rewarded hikes
- weakensDriverAccess to Essential Medicines
- weakensIndicatorProportion of the population with positive out-of-pocket household expenditure on health exceeding 40% of household discretionary budget, by location, quintile, type of household and characteristics of the head of household (%)
Cite this page
Factrail. (2026). US Senate: insulin makers raised list prices in lockstep; PBMs rewarded hikes. Factrail. https://factrail.ai/facts/us-senate-insulin-list-price-pbm-investigation-2021
https://factrail.ai/facts/us-senate-insulin-list-price-pbm-investigation-2021
Accessed 16 October 2026.
By the Factrail desk · Method: how we source and score · Last reviewed
Dispute this factNamed here, or represent someone who is? Request a right of reply.